Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05199233 | COMPLETED | COVID-19

Mindfulness Intervention for Post-Covid Symptoms
Sponsor:

Mayo Clinic

Information provided by (Responsible Party):

Afana, her anal, with a limit

Brief Summary:

The purpose of this study is to assess the feasibility of using a wearable brain-sensing wellness device (Muse-S) to potentially reduce stress and anxiety during Post-Covid, which is characterized by increased stress and anxiety.

Condition or disease

COVID-19

Post Acute Sequelae of SARS-CoV-2

Intervention/treatment

Muse S™ Headband system

Phase

NA

Detailed Description:

This study will answer the following questions: 1) will patients experiencing Long-Covid Syndrome utilize a wearable brain-sensing wellness device to potentially reduce stress and anxiety 2) does using this wearable brain-sensing wellness device help decrease stress and anxiety in patients who are experiencing Long-Covid Syndrome.

Study Type : INTERVENTIONAL
Estimated Enrollment : 45 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : The Benefit of Mindfulness-Based Intervention Using A Wearable Wellness Brain Sensing Device (Muse-S™) in the Treatment of Post-Covid Symptoms
Actual Study Start Date : 2022-06-01
Estimated Primary Completion Date : 2024-11-30
Estimated Study Completion Date : 2024-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Identified with one of 3 Post-Covid Syndrome (PASC) phenotypes at Mayo Clinic Rochester.
  • * Not pregnant by subject self-report at time of consent.
  • * Have the ability to provide informed consent.
  • * Have the ability to complete all aspects of this trial.
  • * Have access to an iPhone, iPad, or Android device.
  • * Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-SÔ system, as determined by the clinical investigators.
Exclusion Criteria
  • * Used an investigational drug within the past 30 days.
  • * Anyone that is not on a stable dose of medication for anxiety, depression or sleep.
  • * Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
  • * Currently (within 3 weeks) has been enrolled in another clinical or research program which intervenes on the patients' QOL, or stress.
  • * An unstable medical or mental health condition as determined by the physician investigator.
Mindfulness Intervention for Post-Covid Symptoms

Location Details

NCT05199233

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, Minnesota

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905